MINI FUTURE OPTIONSSCHEIN PUT - BIOGEN IDEC | Delayed Deutsche Boerse AG 13:04:45 17/06/2024 BST | ||
| 8.12 EUR | +0.25% |
|
| Current month | -6.68% | ||
| 1 month | -4.71% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
BIOGEN INC.
Latest news about BIOGEN INC.
More news
| Date | Price | Change |
|---|---|---|
| 17/06/24 | 8.12 | +0.25% |
| 14/06/24 | 8.1 | +2.40% |
| 13/06/24 | 7.91 | -4.35% |
| 12/06/24 | 8.27 | -3.27% |
| 11/06/24 | 8.55 | -0.35% |
Delayed Quote Deutsche Boerse AG
Last update June 17, 2024 at 01:04 pm
More quotesStatic data
| Product type | Certificat Turbo Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | BIOGEN INC. |
| Issuer | DZ BANK |
| WKN | DJ5S1E |
| ISIN | DE000DJ5S1E4 |
| Date issued | 26/10/2023 |
| Strike | 317 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 6.01 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 12.02 € |
|---|---|
| Lowest since issue | 4.48 € |
| Spread | 0.09 € |
| Spread % | 1.09% |
Company Profile
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows:
- sales of medicines (73,7%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.;
- royalties (17,2%) ;
- other (9,1%): primarily revenues from partnership agreements.
Sector
-
Consensus: Biogen Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
34
Last Close Price
231.7
USD
Average target price
284.6
USD
Spread / Average Target
+22.85%
- Stock Market
- Certificates
- Certificat